Japan Intellectual Property Rights: LISDEXAMFETAMINE DIMESYLATE ORALLY DISPERSIBLE TABLET AND PROCESS FOR PREPARATION THEREOF

Japan, Sept. 18 -- ATHENA PHARMACEUTIQUES SAS has got intellectual property rights for 'LISDEXAMFETAMINE DIMESYLATE ORALLY DISPERSIBLE TABLET AND PROCESS FOR PREPARATION THEREOF.' Other related details are as follows:

Application Number: JP,2024-195503

Category (FI): A61K47/32,A61K31/165,A61K47/26,A61K47/38,A61P25/20,A61K47/04,A61K47/36,A61K47/10,A61P25/00,A61P25/14,A61K47/12,A61K47/02,A61K9/20

Stage: PROBLEM TO BE SOLVED: To provide a lisdexamfetamine dimesylate orally dispensible tablet, and to provide a process for preparation thereof.SOLUTION: The process for preparation of the lisdexamfetamine dimesylate orally dispensible tablet includes: co-sieving lisdexamfetamine dimesylate, a binder, and a diluent; dry-mixing and blending the s...